Literature DB >> 23719772

Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.

Toshiki Sasaki1, Tetsuro Shishido, Shinpei Kadowaki, Tatsuro Kitahara, Satoshi Suzuki, Shigehiko Katoh, Akira Funayama, Shunsuke Netsu, Tetsu Watanabe, Kaoru Goto, Yasuchika Takeishi, Isao Kubota.   

Abstract

Early coronary reperfusion of the ischemic myocardium is a desired therapeutic goal for the preservation of myocardial function. However, reperfusion itself causes additional myocardium injuries. Activation of the diacylglycerol-protein kinase C (DAG-PKC) cascade has been implicated in the cardioprotective effects occurring after ischemia/reperfusion (I/R). DAG kinase (DGK) controls cellular DAG levels by converting DAG to phosphatidic acid, and may act as an endogenous regulator of DAG-PKC signaling. In the present study, we examined the functional role of DGKα in cardiac injury after I/R in in vivo mouse hearts. We generated transgenic mice with cardiac-specific overexpression of DGKα (DGKα-TG). The left anterior descending coronary artery was transiently occluded for 20 min and reperfused for 24 h in DGKα-TG mice and wild-type littermate (WT) mice. The levels of phosphorylation activity of PKCε, extracellular-signal regulated kinase (ERK) 1/2, and p70 ribosomal S6 kinase (p70S6K) were increased after I/R in WT mouse hearts. However, in DGKα-TG mice, activation of PKCε, ERK1/2, and p70S6K was attenuated compared to WT mice. After 24 h, Evans blue/triphenyltetrazolium chloride double staining and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining showed that DGKα-TG mice had significantly larger myocardial infarctions and larger numbers of TUNEL-positive cardiomyocytes than WT mice. Echocardiography and cardiac catheterization revealed that left ventricular systolic function was more severely depressed in DGKα-TG mice than in WT mice after I/R. These findings suggest that DGKα exacerbates I/R injury by inhibiting the cardioprotective effects of PKCε, ERK1/2, and p70S6K activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719772     DOI: 10.1007/s00380-013-0366-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  37 in total

1.  Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.

Authors:  X Fang; S Yu; A Eder; M Mao; R C Bast; D Boyd; G B Mills
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

Review 2.  Phospholipase D: enzymology, mechanisms of regulation, and function.

Authors:  J H Exton
Journal:  Physiol Rev       Date:  1997-04       Impact factor: 37.312

3.  Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infarcted rat hearts: effects of captopril treatment.

Authors:  M Takeda; Y Kagaya; J Takahashi; T Sugie; J Ohta; J Watanabe; K Shirato; H Kondo; K Goto
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

4.  Phosphatidic acid: a potential signal transducer for cardiac hypertrophy.

Authors:  N S Dhalla; Y J Xu; S S Sheu; P S Tappia; V Panagia
Journal:  J Mol Cell Cardiol       Date:  1997-11       Impact factor: 5.000

Review 5.  Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.

Authors:  A L Moens; M J Claeys; J P Timmermans; C J Vrints
Journal:  Int J Cardiol       Date:  2005-04-20       Impact factor: 4.164

6.  Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes.

Authors:  G S Liu; M V Cohen; D Mochly-Rosen; J M Downey
Journal:  J Mol Cell Cardiol       Date:  1999-10       Impact factor: 5.000

7.  Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.

Authors:  Koichi Inagaki; Harvey S Hahn; Gerald W Dorn; Daria Mochly-Rosen
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

8.  Implementation of multiple strategies for improved door-to-balloon time in patients with ST-segment elevation myocardial infarction.

Authors:  Ming-Wei Pan; Shou-Yen Chen; Chun-Chi Chen; Wei-Jan Chen; Chi-Jen Chang; Chia-Pin Lin; Yi-Ming Weng; Yu-Cheng Chen
Journal:  Heart Vessels       Date:  2013-03-19       Impact factor: 2.037

9.  Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.

Authors:  T Miyamoto; Y Takeishi; H Takahashi; T Shishido; T Arimoto; H Tomoike; I Kubota
Journal:  Basic Res Cardiol       Date:  2004-07-21       Impact factor: 17.165

10.  Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.

Authors:  Claire R Weston; Kathryn Balmanno; Claire Chalmers; Kathryn Hadfield; Sarah A Molton; Rebecca Ley; Erwin F Wagner; Simon J Cook
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

View more
  3 in total

1.  Soluble TNF-related apoptosis induced ligand (sTRAIL) is augmented by Post-Conditioning and correlates to infarct size and left ventricle dysfunction in STEMI patients: a substudy from a randomized clinical trial.

Authors:  André Luz; Mário Santos; Rui Magalhães; José Carlos Oliveira; Ana Pacheco; João Silveira; Sofia Cabral; Severo Torres; Adelino F Leite-Moreira; Henrique Carvalho
Journal:  Heart Vessels       Date:  2016-05-26       Impact factor: 2.037

2.  Effects of Renal Ischemic Postconditioning on Myocardial Ultrastructural Organization and Myocardial Expression of Bcl-2/Bax in Rabbits.

Authors:  Wen-Zhong Zhang; Rong Li; Song Liu; Ji-Dong Zhang; Xian-Feng Ning; Shang-Lang Cai
Journal:  Biomed Res Int       Date:  2016-12-20       Impact factor: 3.411

3.  Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion.

Authors:  Shinpei Kadowaki; Tetsuro Shishido; Toshiki Sasaki; Takayuki Sugai; Taro Narumi; Yuki Honda; Yoichiro Otaki; Daisuke Kinoshita; Tetsuya Takahashi; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Akihiko Ishigami; Yasuchika Takeishi; Isao Kubota
Journal:  Int J Mol Sci       Date:  2016-04-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.